Global HIV Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

November 2018 | 121 pages | ID: GA2AF581668EN
GlobalInfoResearch

Abstracts

The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss of ability to fight against the organism that causes disease.

Scope of the Report:

HIV spreads through fluidic exchange with some infected person such as blood transfer or sharing needles with someone who is HIV infected. In addition, HIV can spread from infected mother to child during pregnancy. Some of the symptoms of HIV infection are slight fever, fatigue, swollen glands, headaches and muscle aches.
HIV infection has no cure but there are treatments which help to stabilize or reduce this infection so that it does not lead to AIDS. HIV therapeutics market is growing at a significant rate due to increase in the HIV infected cases and growing awareness about the same. HIV infection can be treated by various therapeutics such as nucleoside/ nucleotide reverse transcriptase inhibitor, integrase inhibitor, HIV-1 protease inhibitor, non-nucleoside reverse transcriptase inhibitor, pharmacokinetic enhancer and entry inhibitor.
The global HIV Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of HIV Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the HIV Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the HIV Therapeutics market by product type and applications/end industries.

Market Segment by Companies, this report covers

• Boehringer Ingelheim International GmbH
• Merck & Co.
• ViiV Healthcare
• AbbVie
• F. Hoffmann-La Roche Ltd.
• Teva Pharmaceutical Industries Ltd.
• Bristol-Myers Squibb
• Gilead Sciences
• Johnson & Johnson
• Cipla Limited

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
• Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
• Entry and Fusion Inhibitors
• Protease Inhibitors (PIs)
• Integrase Inhibitors
• Coreceptor Antagonists

Market Segment by Applications, can be divided into

• Hospitals
• Clinics
• Labs

Contents

1 HIV THERAPEUTICS MARKET OVERVIEW

1.1 Product Overview and Scope of HIV Therapeutics
1.2 Classification of HIV Therapeutics by Types
  1.2.1 Global HIV Therapeutics Revenue Comparison by Types (2017-2023)
  1.2.2 Global HIV Therapeutics Revenue Market Share by Types in 2017
  1.2.3 Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
  1.2.4 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
  1.2.5 Entry and Fusion Inhibitors
  1.2.6 Protease Inhibitors (PIs)
  1.2.7 Integrase Inhibitors
  1.2.8 Coreceptor Antagonists
1.3 Global HIV Therapeutics Market by Application
  1.3.1 Global HIV Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Labs
1.4 Global HIV Therapeutics Market by Regions
  1.4.1 Global HIV Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) HIV Therapeutics Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) HIV Therapeutics Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) HIV Therapeutics Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) HIV Therapeutics Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) HIV Therapeutics Status and Prospect (2013-2023)
1.5 Global Market Size of HIV Therapeutics (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Boehringer Ingelheim International GmbH
  2.1.1 Business Overview
  2.1.2 HIV Therapeutics Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Boehringer Ingelheim International GmbH HIV Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merck & Co.
  2.2.1 Business Overview
  2.2.2 HIV Therapeutics Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Merck & Co. HIV Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.3 ViiV Healthcare
  2.3.1 Business Overview
  2.3.2 HIV Therapeutics Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 ViiV Healthcare HIV Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.4 AbbVie
  2.4.1 Business Overview
  2.4.2 HIV Therapeutics Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 AbbVie HIV Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.5 F. Hoffmann-La Roche Ltd.
  2.5.1 Business Overview
  2.5.2 HIV Therapeutics Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 F. Hoffmann-La Roche Ltd. HIV Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.6 Teva Pharmaceutical Industries Ltd.
  2.6.1 Business Overview
  2.6.2 HIV Therapeutics Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Teva Pharmaceutical Industries Ltd. HIV Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bristol-Myers Squibb
  2.7.1 Business Overview
  2.7.2 HIV Therapeutics Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Bristol-Myers Squibb HIV Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.8 Gilead Sciences
  2.8.1 Business Overview
  2.8.2 HIV Therapeutics Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Gilead Sciences HIV Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.9 Johnson & Johnson
  2.9.1 Business Overview
  2.9.2 HIV Therapeutics Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Johnson & Johnson HIV Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.10 Cipla Limited
  2.10.1 Business Overview
  2.10.2 HIV Therapeutics Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Cipla Limited HIV Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL HIV THERAPEUTICS MARKET COMPETITION, BY PLAYERS

3.1 Global HIV Therapeutics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 HIV Therapeutics Players Market Share
  3.2.2 Top 10 HIV Therapeutics Players Market Share
3.3 Market Competition Trend

4 GLOBAL HIV THERAPEUTICS MARKET SIZE BY REGIONS

4.1 Global HIV Therapeutics Revenue and Market Share by Regions
4.2 North America HIV Therapeutics Revenue and Growth Rate (2013-2018)
4.3 Europe HIV Therapeutics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific HIV Therapeutics Revenue and Growth Rate (2013-2018)
4.5 South America HIV Therapeutics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa HIV Therapeutics Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA HIV THERAPEUTICS REVENUE BY COUNTRIES

5.1 North America HIV Therapeutics Revenue by Countries (2013-2018)
5.2 USA HIV Therapeutics Revenue and Growth Rate (2013-2018)
5.3 Canada HIV Therapeutics Revenue and Growth Rate (2013-2018)
5.4 Mexico HIV Therapeutics Revenue and Growth Rate (2013-2018)

6 EUROPE HIV THERAPEUTICS REVENUE BY COUNTRIES

6.1 Europe HIV Therapeutics Revenue by Countries (2013-2018)
6.2 Germany HIV Therapeutics Revenue and Growth Rate (2013-2018)
6.3 UK HIV Therapeutics Revenue and Growth Rate (2013-2018)
6.4 France HIV Therapeutics Revenue and Growth Rate (2013-2018)
6.5 Russia HIV Therapeutics Revenue and Growth Rate (2013-2018)
6.6 Italy HIV Therapeutics Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC HIV THERAPEUTICS REVENUE BY COUNTRIES

7.1 Asia-Pacific HIV Therapeutics Revenue by Countries (2013-2018)
7.2 China HIV Therapeutics Revenue and Growth Rate (2013-2018)
7.3 Japan HIV Therapeutics Revenue and Growth Rate (2013-2018)
7.4 Korea HIV Therapeutics Revenue and Growth Rate (2013-2018)
7.5 India HIV Therapeutics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia HIV Therapeutics Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA HIV THERAPEUTICS REVENUE BY COUNTRIES

8.1 South America HIV Therapeutics Revenue by Countries (2013-2018)
8.2 Brazil HIV Therapeutics Revenue and Growth Rate (2013-2018)
8.3 Argentina HIV Therapeutics Revenue and Growth Rate (2013-2018)
8.4 Colombia HIV Therapeutics Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE HIV THERAPEUTICS BY COUNTRIES

9.1 Middle East and Africa HIV Therapeutics Revenue by Countries (2013-2018)
9.2 Saudi Arabia HIV Therapeutics Revenue and Growth Rate (2013-2018)
9.3 UAE HIV Therapeutics Revenue and Growth Rate (2013-2018)
9.4 Egypt HIV Therapeutics Revenue and Growth Rate (2013-2018)
9.5 Nigeria HIV Therapeutics Revenue and Growth Rate (2013-2018)
9.6 South Africa HIV Therapeutics Revenue and Growth Rate (2013-2018)

10 GLOBAL HIV THERAPEUTICS MARKET SEGMENT BY TYPE

10.1 Global HIV Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Global HIV Therapeutics Market Forecast by Type (2018-2023)
10.3 Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) Revenue Growth Rate (2013-2023)
10.4 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Revenue Growth Rate (2013-2023)
10.5 Entry and Fusion Inhibitors Revenue Growth Rate (2013-2023)
10.6 Protease Inhibitors (PIs) Revenue Growth Rate (2013-2023)
10.7 Integrase Inhibitors Revenue Growth Rate (2013-2023)
10.8 Coreceptor Antagonists Revenue Growth Rate (2013-2023)

11 GLOBAL HIV THERAPEUTICS MARKET SEGMENT BY APPLICATION

11.1 Global HIV Therapeutics Revenue Market Share by Application (2013-2018)
11.2 HIV Therapeutics Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Labs Revenue Growth (2013-2018)

12 GLOBAL HIV THERAPEUTICS MARKET SIZE FORECAST (2018-2023)

12.1 Global HIV Therapeutics Market Size Forecast (2018-2023)
12.2 Global HIV Therapeutics Market Forecast by Regions (2018-2023)
12.3 North America HIV Therapeutics Revenue Market Forecast (2018-2023)
12.4 Europe HIV Therapeutics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific HIV Therapeutics Revenue Market Forecast (2018-2023)
12.6 South America HIV Therapeutics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa HIV Therapeutics Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure HIV Therapeutics Picture
Table Product Specifications of HIV Therapeutics
Table Global HIV Therapeutics and Revenue (Million USD) Market Split by Product Type
Figure Global HIV Therapeutics Revenue Market Share by Types in 2017
Figure Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) Picture
Figure Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Picture
Figure Entry and Fusion Inhibitors Picture
Figure Protease Inhibitors (PIs) Picture
Figure Integrase Inhibitors Picture
Figure Coreceptor Antagonists Picture
Table Global HIV Therapeutics Revenue (Million USD) by Application (2013-2023)
Figure HIV Therapeutics Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Clinics Picture
Figure Labs Picture
Table Global Market HIV Therapeutics Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America HIV Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe HIV Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific HIV Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America HIV Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa HIV Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global HIV Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Table Boehringer Ingelheim International GmbH Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim International GmbH HIV Therapeutics Type and Applications
Table Boehringer Ingelheim International GmbH HIV Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Merck & Co. Basic Information, Manufacturing Base and Competitors
Table Merck & Co. HIV Therapeutics Type and Applications
Table Merck & Co. HIV Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table ViiV Healthcare Basic Information, Manufacturing Base and Competitors
Table ViiV Healthcare HIV Therapeutics Type and Applications
Table ViiV Healthcare HIV Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie HIV Therapeutics Type and Applications
Table AbbVie HIV Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche Ltd. HIV Therapeutics Type and Applications
Table F. Hoffmann-La Roche Ltd. HIV Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Industries Ltd. HIV Therapeutics Type and Applications
Table Teva Pharmaceutical Industries Ltd. HIV Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb HIV Therapeutics Type and Applications
Table Bristol-Myers Squibb HIV Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences HIV Therapeutics Type and Applications
Table Gilead Sciences HIV Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson HIV Therapeutics Type and Applications
Table Johnson & Johnson HIV Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Cipla Limited Basic Information, Manufacturing Base and Competitors
Table Cipla Limited HIV Therapeutics Type and Applications
Table Cipla Limited HIV Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Global HIV Therapeutics Revenue (Million USD) by Players (2013-2018)
Table Global HIV Therapeutics Revenue Share by Players (2013-2018)
Figure Global HIV Therapeutics Revenue Share by Players in 2016
Figure Global HIV Therapeutics Revenue Share by Players in 2017
Figure Global Top 5 Players HIV Therapeutics Revenue Market Share in 2017
Figure Global Top 10 Players HIV Therapeutics Revenue Market Share in 2017
Figure Global HIV Therapeutics Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global HIV Therapeutics Revenue (Million USD) by Regions (2013-2018)
Table Global HIV Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global HIV Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global HIV Therapeutics Revenue Market Share by Regions in 2017
Figure North America HIV Therapeutics Revenue and Growth Rate (2013-2018)
Figure Europe HIV Therapeutics Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific HIV Therapeutics Revenue and Growth Rate (2013-2018)
Figure South America HIV Therapeutics Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa HIV Therapeutics Revenue and Growth Rate (2013-2018)
Table North America HIV Therapeutics Revenue by Countries (2013-2018)
Table North America HIV Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America HIV Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America HIV Therapeutics Revenue Market Share by Countries in 2017
Figure USA HIV Therapeutics Revenue and Growth Rate (2013-2018)
Figure Canada HIV Therapeutics Revenue and Growth Rate (2013-2018)
Figure Mexico HIV Therapeutics Revenue and Growth Rate (2013-2018)
Table Europe HIV Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Europe HIV Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Europe HIV Therapeutics Revenue Market Share by Countries in 2017
Figure Germany HIV Therapeutics Revenue and Growth Rate (2013-2018)
Figure UK HIV Therapeutics Revenue and Growth Rate (2013-2018)
Figure France HIV Therapeutics Revenue and Growth Rate (2013-2018)
Figure Russia HIV Therapeutics Revenue and Growth Rate (2013-2018)
Figure Italy HIV Therapeutics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific HIV Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific HIV Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific HIV Therapeutics Revenue Market Share by Countries in 2017
Figure China HIV Therapeutics Revenue and Growth Rate (2013-2018)
Figure Japan HIV Therapeutics Revenue and Growth Rate (2013-2018)
Figure Korea HIV Therapeutics Revenue and Growth Rate (2013-2018)
Figure India HIV Therapeutics Revenue and Growth Rate (2013-2018)
Figure Southeast Asia HIV Therapeutics Revenue and Growth Rate (2013-2018)
Table South America HIV Therapeutics Revenue by Countries (2013-2018)
Table South America HIV Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America HIV Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America HIV Therapeutics Revenue Market Share by Countries in 2017
Figure Brazil HIV Therapeutics Revenue and Growth Rate (2013-2018)
Figure Argentina HIV Therapeutics Revenue and Growth Rate (2013-2018)
Figure Colombia HIV Therapeutics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa HIV Therapeutics Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa HIV Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa HIV Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa HIV Therapeutics Revenue Market Share by Countries in 2017
Figure Saudi Arabia HIV Therapeutics Revenue and Growth Rate (2013-2018)
Figure UAE HIV Therapeutics Revenue and Growth Rate (2013-2018)
Figure Egypt HIV Therapeutics Revenue and Growth Rate (2013-2018)
Figure Nigeria HIV Therapeutics Revenue and Growth Rate (2013-2018)
Figure South Africa HIV Therapeutics Revenue and Growth Rate (2013-2018)
Table Global HIV Therapeutics Revenue (Million USD) by Type (2013-2018)
Table Global HIV Therapeutics Revenue Share by Type (2013-2018)
Figure Global HIV Therapeutics Revenue Share by Type (2013-2018)
Figure Global HIV Therapeutics Revenue Share by Type in 2017
Table Global HIV Therapeutics Revenue Forecast by Type (2018-2023)
Figure Global HIV Therapeutics Market Share Forecast by Type (2018-2023)
Figure Global Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) Revenue Growth Rate (2013-2018)
Figure Global Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Revenue Growth Rate (2013-2018)
Figure Global Entry and Fusion Inhibitors Revenue Growth Rate (2013-2018)
Figure Global Protease Inhibitors (PIs) Revenue Growth Rate (2013-2018)
Figure Global Integrase Inhibitors Revenue Growth Rate (2013-2018)
Figure Global Coreceptor Antagonists Revenue Growth Rate (2013-2018)
Table Global HIV Therapeutics Revenue by Application (2013-2018)
Table Global HIV Therapeutics Revenue Share by Application (2013-2018)
Figure Global HIV Therapeutics Revenue Share by Application (2013-2018)
Figure Global HIV Therapeutics Revenue Share by Application in 2017
Table Global HIV Therapeutics Revenue Forecast by Application (2018-2023)
Figure Global HIV Therapeutics Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Clinics Revenue Growth Rate (2013-2018)
Figure Global Labs Revenue Growth Rate (2013-2018)
Figure Global HIV Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global HIV Therapeutics Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global HIV Therapeutics Revenue Market Share Forecast by Regions (2018-2023)
Figure North America HIV Therapeutics Revenue Market Forecast (2018-2023)
Figure Europe HIV Therapeutics Revenue Market Forecast (2018-2023)
Figure Asia-Pacific HIV Therapeutics Revenue Market Forecast (2018-2023)
Figure South America HIV Therapeutics Revenue Market Forecast (2018-2023)
Figure Middle East and Africa HIV Therapeutics Revenue Market Forecast (2018-2023)